Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Endourologic treatment of upper urinary tract transitional cell carcinoma

Nature Clinical Practice Urology volume 2, pages 376–383 (2005)Cite this article

Abstract

The traditional treatment for upper tract transitional cell carcinoma (UTTCC) consists of radical nephroureterectomy. A more conservative approach, however, was required in cases of bilateral UTTCC and in patients with disease in a solitary kidney but who had underlying comorbidities that made them unsuitable candidates for open surgery. Minimally invasive treatment methods were developed for these select groups of patients. Because of technological advancements and refinement in endoscopic techniques, most patients with UTTCC, even those with normal contralateral kidneys, can now be offered minimally invasive treatment with single or multimodal approaches involving ureteroscopy or percutaneous resection. For patients with low-stage, low-grade UTTCC, five-year survival rates are comparable for those treated endourologically and those treated by nephroureterectomy. High-grade lesions have much higher recurrence and progression rates than lower-grade lesions, and nephroureterectomy is therefore recommended in patients with high-grade disease. The use of adjuvant instillation in the treatment of UTTCC, administered via antegrade and retrograde methods, has been shown to improve outcomes. For recurrences to be diagnosed and treated in a timely manner, and acceptable cancer-free survival rates maintained, long-term rigorous follow-up after endourologic treatment, with regular surveillance ureteroscopy, is crucial.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Fraley EE (1978) Cancer of the renal pelvis. In Genitourinary Cancer, 134 (Eds Skinner DG and deKernion JB) Philadelphia: WB Saunders

    Google Scholar 

  2. Keeley FX et al. (1997) Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol 157: 1560–1565

    Article  Google Scholar 

  3. Anderstrom C et al. (1989) Carcinoma of the ureter: a clinicopathologic study of 49 cases. J Urol 124: 23

    Article  Google Scholar 

  4. Strong DW et al. (1976) The ureteral stump after nephroureterectomy. J Urol 115: 654–655

    Article  CAS  Google Scholar 

  5. Huffman JL et al. (1985) Endoscopic diagnosis and treatment of upper tract urothelial tumors. A preliminary report. Cancer 55: 1422–1428

    Article  CAS  Google Scholar 

  6. Streem SB and Pontes EJ (1986) Percutaneous management of upper tract transitional cell carcinoma. J Urol 135: 773–775

    Article  CAS  Google Scholar 

  7. Keeley FX et al. (1997) Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 157: 33–37

    Article  CAS  Google Scholar 

  8. Chen GL and Bagley DH (2001) Ureteroscopic surgery for upper tract transitional cell carcinoma: complications and management. J Endourol 15: 399–404

    Article  CAS  Google Scholar 

  9. Abdel-Razzak OM et al. (1994) Ureteroscopic biopsy in the upper urinary tract. Urology 44: 451–457

    Article  CAS  Google Scholar 

  10. Daneshmand S et al. (2003) Endoscopic management of upper urinary, tract transitional cell carcinoma: Long-term experience. Cancer 98: 55–60

    Article  Google Scholar 

  11. Elliott DS et al. (1996) Long-term follow up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology 47: 819–825

    Article  CAS  Google Scholar 

  12. Tasca A et al. (1992) Endourologic treatment of transitional cell carcinoma of the upper urinary tract. J Endourol 6: 253–256

    Article  Google Scholar 

  13. Carson CC (1991) Endoscopic treatment of upper and lower urinary tract lesions using lasers. Sem Urol 9: 185–191

    Google Scholar 

  14. Schilling A et al. (1986) Use of the neodyrnium-YAG laser in the treatment of ureteral tumors and urethral condylomata acuminata. Clinical experience. Eur Urol 12 (Suppl 1): S30–S33

    Article  Google Scholar 

  15. Malloy TR et al. (1986) Renal preservation utilizing neodymium:YAG laser. Urology 27: 99–103

    Article  CAS  Google Scholar 

  16. Bagley DH (2001) Laser treatment of urothelial tumors. In Endourologic use of the holmium laser, 29–36 (Eds Bagley DH and Das AK) Jackson (WY): Teton NewMedia

    Google Scholar 

  17. Johnson DE (1994) Use of the holmium:YAG laser for treatment of superficial bladder carcinoma. Lasers Surg Med 14: 213–218

    Article  CAS  Google Scholar 

  18. Razvi HA et al. (1995) Soft-tissue applications of the holmium:YAG laser in urology. J Endourol 9: 387–390

    Article  CAS  Google Scholar 

  19. Bagley DH and Erhard M (1995) Use of the holmium laser in the upper urinary tract. Tech Urol 1: 25–30

    CAS  PubMed  Google Scholar 

  20. Bagley DH et al. (1985) Endoscopic diagnosis and treatment of upper tract urothelial tumors—a preliminary report. Cancer 55: 1422–1428

    Article  Google Scholar 

  21. Palou J et al. (2004) Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. J Urol 172: 66–69

    Article  Google Scholar 

  22. Jarrett TW et al. (1995) Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience. J Urol 154: 1629–1635

    Article  CAS  Google Scholar 

  23. Clark PE et al. (1999) 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J Urol 161: 772–776

    Article  CAS  Google Scholar 

  24. Jabbour ME et al. (2000) Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome. J Urol 163: 1105–1107

    Article  CAS  Google Scholar 

  25. Liatsikos EN et al. (2001) Transitional-cell carcinoma of the renal pelvis: ureteroscopic and percutaneous approach. J Endourol 5: 377–383

    Article  Google Scholar 

  26. Patel A et al. (1996) Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis. J Urol 155: 868–874

    Article  CAS  Google Scholar 

  27. Plancke HR et al. (1995) Percutaneous endoscopic treatment of urothelial tumours of the renal pelvis. Br J Urol 75: 736–739

    Article  CAS  Google Scholar 

  28. Lee BR et al. (1999) 13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: Equivalent outcomes. J Endourol 13: 289–294

    Article  CAS  Google Scholar 

  29. Martinez-Pineiro JA et al. (1996) Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J Urol 156: 377–385

    Article  CAS  Google Scholar 

  30. Jabbour ME and Smith AD (2000) Primary percutaneous approach to upper urinary tract transitional cell carcinoma. Urol Clin N Am 27: 739–750

    Article  CAS  Google Scholar 

  31. Guinan P (1992) Renal pelvic cancer: a review of 611 patients treated in Illinois 1975–1985. J Urol 40: 393–399

    Article  CAS  Google Scholar 

  32. Shelley MD et al. (2001) A systematic review of intravesical bacillus Calmette–Guérin plus transurethral resection vs. transurethral resection alone in Ta and T1 bladder cancer. BJU Int 88: 209–216

    Article  CAS  Google Scholar 

  33. Herr HW (1985) Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette–Guérin. J Urol 134: 531–532

    Article  CAS  Google Scholar 

  34. Irie A et al. (2002) Intravesical instillation of bacille Calmette–Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter. Urology 59: 53–57

    Article  Google Scholar 

  35. Patel A and Fuchs GJ (1998) New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma. J Urol 159: 71–75

    Article  CAS  Google Scholar 

  36. Thalmann GN et al. (2002) Long term experience with bacillus Calmette–Guérin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol 168: 1381–1385

    Article  Google Scholar 

  37. Oefelein MG and MacLennan G (2003) Transitional cell carcinoma recurrence in the nephrostomy tract after percutaneous resection. J Urol 170: 521

    Article  Google Scholar 

  38. Huang A et al. (1995) Nephrostomy tract tumor seeding following percutaneous manipulation of a ureteral carcinoma. J Urol 153: 1041–1042

    Article  CAS  Google Scholar 

  39. Schoenberg MP et al. (1991) The management of transitional cell carcinoma in solitary renal units. J Urol 146: 700–703

    Article  CAS  Google Scholar 

  40. Okubo K et al. (2001) Intrarenal bacillus Calmette–Guérin therapy for carcinoma in situ of the upper urinary tract: long term follow-up and natural course in cases of failure. BJU Int 88: 343–347

    Article  CAS  Google Scholar 

  41. Hayashida Y et al. (2004) Long-term effects of bacillus Calmette–Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of the upper urinary tract. Urology 63: 1084–1088

    Article  Google Scholar 

  42. Nadler RB et al. (1994) Durability of the tumor-free response for intravesical bacillus Calmette–Guérin therapy. J Urol 152: 367

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laparoscopy Section,

    Michael C Ost, Brian A VanderBrink, Benjamin R Lee & Arthur D Smith

  2. Department of Urology, Long Island Jewish Medical Center, New Hyde Park, New York, USA

    Michael C Ost, Brian A VanderBrink, Benjamin R Lee & Arthur D Smith

Authors
  1. Michael C Ost
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian A VanderBrink
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Benjamin R Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arthur D Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arthur D Smith.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ost, M., VanderBrink, B., Lee, B. et al. Endourologic treatment of upper urinary tract transitional cell carcinoma. Nat Rev Urol 2, 376–383 (2005). https://doi.org/10.1038/ncpuro0250

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0250

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing